A Nurse Cohort Study in Xiamen, China
A Prospective Cohort Study of Common Chronic Diseases on Nurses in Xiamen, China: Nurse Cohort Study Xiamen (NCSX)
1 other identifier
observational
10,000
1 country
1
Brief Summary
The Nurse Cohort Study Xiamen (NCSX) is an open-ended prospective cohort study with very broad research aims. The primary objectives of the NCSX is planned to examine genetic, epigenetic, biological, psychological, social, lifestyle and other environmental factors of nurses in relation to incidence and progression of the common chronic diseases, such as hypertension, ischemic heart disease, stroke, diabetes, chronic kidney disease and some cancers, which are emerging with economic development in Xiamen, China. Specifically, we intend to test whether empirically driven hypothesis and emerging risk factors mainly developed in response to observations in economically developed Western societies apply in a population living in a rapid changing lifestyle in China now.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2019
CompletedFirst Posted
Study publicly available on registry
January 10, 2019
CompletedStudy Start
First participant enrolled
March 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
ExpectedNovember 3, 2023
November 1, 2023
4.8 years
January 8, 2019
November 2, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence rate
The incidence rates of common chronic diseases, such as hypertension, The stroke, CKD and cancers
2019.1.21-2024.12.31
Secondary Outcomes (1)
Mortality
2019.1.21-2024.12.31
Study Arms (1)
Nurses
All subjects are registered nurses in Xiamen, China
Interventions
Eligibility Criteria
* Registered nurses in public hospitals in Xiamen, China; * Aged 20 years or over and living in Xiamen for at least 1 year and will not move out of Xiamen for at least 5 years;
You may qualify if:
- Registered nurses of public hospitals in Xiamen, China;
- aged 20 years or over;
- Working in the public hospitals for at least 1 year;
- Signed the informed consent and agreed to participate in the study;
- Assuming not moved out of Xiamen for at least 5 years;
You may not qualify if:
- who are unambulatory;
- who are receiving treatment modalities, which , if omitted, may result in immediate life threatening risk such as chemotherapy or radiotherapy for cancer, or dialysis for renal failure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, 361003, China
Biospecimen
serum, plasma and urin.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Weihua Li, Ph.D.
The First Affiliated Hospital of Xiamen University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
January 8, 2019
First Posted
January 10, 2019
Study Start
March 20, 2019
Primary Completion
December 31, 2023
Study Completion (Estimated)
December 31, 2028
Last Updated
November 3, 2023
Record last verified: 2023-11